Predictors and Clinical Impact of Atrial Fibrillation after Pacemaker Implantation in Elderly Patients Treated with Dual Chamber Versus Ventricular Pacing

PACE - Pacing and Clinical Electrophysiology

Volumn 26, Issue 10, 2003, Pages 2000-2007

  Stambler, Bruce S ^a   Ellenbogen, Kenneth A ^b   Orav, E John ^c   Sgarbossa, Elena B ^d   Estes III, N A Mark ^e   Rizo Patron, Carlos ^f   Kirchhoffer, James B ^g   Hadjis, Tom A ^h   Goldman, Lee ⁱ   Lamas, Gervasio A ^j  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d RUSH UNIVERSITY MEDICAL CENTER   (United States)

^e TUFTS MEDICAL CENTER   (United States)

^f Cardiology Associates of Lubbock   (United States)

^g BAYSTATE MEDICAL CENTER   (United States)

^h MONTREAL GENERAL HOSPITAL   (Canada)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j MOUNT SINAI MEDICAL CENTER   (United States)

more..

Author keywords

Atrial fibrillation; Pacemaker; Sinoatrial node

Indexed keywords

AGED; ANAMNESIS; ARTICLE; ARTIFICIAL HEART PACEMAKER; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELDERLY CARE; FEMALE; FOLLOW UP; HEART ASSIST DEVICE; HEART ATRIUM FIBRILLATION; HEART DEATH; HEART FAILURE; HEART VENTRICLE PACING; HOSPITALIZATION; HUMAN; HYPERTENSION; IMPLANTATION; INCIDENCE; INTERMETHOD COMPARISON; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; POSTOPERATIVE PERIOD; PREDICTION; PREOPERATIVE EVALUATION; PROSPECTIVE STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; RISK ASSESSMENT; SCORING SYSTEM; SINGLE BLIND PROCEDURE; SINUS NODE DYSFUNCTION; STROKE; SUPRAVENTRICULAR TACHYCARDIA; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; CARDIAC PACING, ARTIFICIAL; FEMALE; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; SINGLE-BLIND METHOD;

EID: 10744226395     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9592.2003.00309.x     Document Type: Article

References (17)

1. Lamas GA, Orav EJ, Stambler BS, et al., for the Pacemaker Selection in the Elderly Investigators. Quality of life and clinical outcomes in elderly patients treated with ventricular pacing as compared with dual-chamber pacing. N Engl J Med 1998; 338:1097-1104.
2. Connolly SJ, Kerr CR, Gent M, et al. for the Canadian Trial of Physiologic Pacing Investigators. Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. N Engl J Med 2000; 342:1385-1391.
3. Lamas G, Lee K, Sweeney M, et al. Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. N Engl J Med 2002; 346:1854-1862.
4. Skanes AC, Krahn AD, Yee R, et al. Progression to chronic atrial fibrillation after pacing: The Canadian Trial of Physiologic Pacing. J Am Coll Cardiol 2001; 38:167-172.
5. Gillis AM, Kerr CR. Whither physiologic pacing? Implications of CTOPP. PACE 2000; 23:1193-1196.
6. Sgarbossa EB, Pinski SL, Maloney JD, et al. Chronic atrial fibrillation and stroke in paced patients with sick sinus syndrome: Relevance of clinical characteristics and pacing modalities. Circulation 1993; 88:1045-1053.
7. Andersen HR, Thuesen L, Bagger JP, et al. Prospective randomised trial of atrial versus ventricular pacing in sick-sinus syndrome. Lancet 1994; 344:1523-1528.
8. Andersen HR, Nielsen JC, Thomsen PEB, et al. Long-term follow-up of patients from a randomized trial of atrial versus ventricular pacing for sick-sinus syndrome. Lancet 1997; 350:1210-1216.
9. Benjamin EJ, Levy D, Vaziri SM, et al. Independent risk factors for atrial fibrillation in a population-based cohort: the Framingham Heart Study. JAMA 1994; 271:840-844.
10. Kannel WB, Wolf PA, Benjamin EJ, et al. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: Population-based estimates. Am J Cardiol 1998; 82:2N-9N.
11. Benditt DG, Sakaguchi S, Goldstein MA, et al. Sinus node dysfunction: Pathophysiology, clinical features, evaluation and treatment. In DP Zipes, J Jalife (eds.): Cardiac Electrophysiology: From Cell to Bedside, 2nd Ed. Philadelphia, WB Saunders, 1995, pp. 1215-1247.
12. Jung W, Luderitz B. Quality of life in patients with atrial fibrillation. J Cardiovasc Electrophysiol 1998; 9:S177-S186.
13. Dorian P, Jung W, Newman D, et al. The impairment of health-related quality of life in patients with intermittent atrial fibrillation: Implications for the assessment of investigational therapy. J Am Coll Cardiol 2000; 36:1303-1309.
14. Hohnloser SH, Kuck KH, Lilienthal J. Rhythm or rate control in atrial fibrillation- Pharmacological Intervention in Atrial Fibrillation (PIAF): A randomised trial. Lancet 2000; 356:1789-1794.
15. Brignole M, Gianfranchi L, Menozzi C, et al. Influence of atrioventricular junction radiofrequency ablation in patients with chronic atrial fibrillation and flutter on quality of life and cardiac performance. Am J Cardiol 1994; 74:242-246.
16. Bubien RS, Knotts-Dolson SM, Plumb VJ, et al. Effect of radiofrequency catheter ablation on health-related quality of life and activities of daily living in patients with recurrent arrhythmias. Circulation 1996; 94:1585-1591.
17. Wood MA, Brown-Mahoney C, Kay GN, et al. Clinical outcomes after ablation and pacing therapy for atrial fibrillation : A meta-analysis. Circulation 2000; 101:1138-1144.